Pay in 4 interest-free payments of $6.50 Learn more
Ships within 48 hours · Estimated delivery Oct 16 - Oct 21
Lilly is also running two other trials with eloralintide plus tirzepatide, including another mid-stage study in obese and overweight type 2 diabetes patients, with an initial completion date in June 2026, and a Phase I trial in nondiabetic individuals, scheduled to complete in October 2025
The slower titration reduces gastrointestinal side effects
Mounjaro works in a manner similar to the naturally occurring hormone, GLUT-1, and can influence various parts of the body, potentially leading to body aches
GLP-1 Affordability Challenges Consumers enrolled in high-deductible health plans (HDHPs) often encounter even greater affordability challenges because prescription drug coverage may not significantly reduce costs until deductibles are met
doi:10.1111/bph.14116
US$ 28.08
US$ 24.31
US$ 23.18
US$ 20.68
US$ 25.86
US$ 22.75
